New Community Hospital East president pursues care for all
The new president of Community Hospital East says her job is all about health—the health of not just patients, but
the entire neighborhood.
Health Care
Articles
Lilly settles Zyprexa suit with S. Carolina
Eli Lilly and Co. has agreed to settle the State of South Carolina’s lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.
Proposed Fishers medical park faces uncertain demand
Fishers development officials hope to create a huge cluster of medical and research facilities near Interstate 69’s Exit
10, near St. Vincent Medical Center Northeast, but local real estate experts disagree about the amount of potential demand
for such a development.
Rolls-Royce and health care reform
Rolls-Royce, the British jet engine maker, isn’t taking a position on health care reform, but let’s drag them into it, anyway,
because Rolls-Royce’s business model might interest the crowd advocating for reform via market forces.
Proposed Medicaid change splits state nursing homes
The Indiana Division of Aging wants to change Medicaid rates to nursing homes to reward quality care and penalize the lack
of it, leaving the industry divided over whether to support the groundbreaking rule or to seek revisions and a slower phase-in.
Indiana hospitals settle Medicare lawsuit
Six hospital systems, including three in Indiana, have agreed to pay the federal government $8.3 million to settle a whistleblower
lawsuit alleging the hospitals deliberately overcharged Medicare for routine back surgeries.
St. Francis resumes work on $265M project
With its financial performance exceeding expectations, St. Francis Hospital & Health Centers will resume construction on a $265 million, 221-bed patient tower at its Indianapolis campus, the hospital system announced Thursday.
Clarian CEO pines anew for public insurance option
Most business groups cheered when Sen. Max Baucus, D-Mont., introduced a health reform bill with no so-called public option,
a controversial government-run insurance plan for working adults. But there’s a big group that would like
to see it back on the table—hospitals.
Region below average on Obama’s health care cost measure
The tool the administration is using to measure waste shows that expenses in Indianapolis might be low enough
not to get whacked. But the region isn’t performing so well that it’s likely to get much praise, either.
Mead Johnson plans expansion in Evansville
Mead Johnson Nutrition plans to spend nearly $33 million at a southwestern Indiana facility where it plans to start making
powdered infant formula products.
Lilly: Alimta improves lung-cancer survival time
Indianapolis-based Eli Lilly and Co. announced today that a clinical trial showed lung cancer patients treated with Lilly
drug Alimta lived about three months longer than those who received the best available care.
Hill-Rom begins CEO search under succession plan
Medical equipment supplier Hill-Rom Holdings Inc. said yesterday it has begun a chief executive search to plan for the retirement
of current CEO Peter Soderberg.
Weight-loss challenges at local firms raise money for charity
Employees at five different companies collectively lost 805 pounds over six weeks this summer. They also
raised $805 for Big Brothers/Big Sisters of Central Indiana.
MARCUS: Whose fault is poor health?
Where once we believed people were victims of disease, we now insist
that illness is a reflection of choices actively made.
Local health care industry tries to capitalize on migraine headaches
Migraines cost American employers $20 billion a year in decreased worker productivity. Such
a frequent and uncured disease stands as a huge business opportunity for the health care industry, including locally based pharmaceutical giant Eli Lilly and Co.
UPDATE: Pipeline challenges force Lilly restructuring moves
Since John Lechleiter was named CEO 18 months ago, he’s bet that Eli Lilly and Co. could face down its looming patent challenges
by launching innovative new medicines. Today’s announcement of 5,500 job cuts by the end of 2011 and a restructuring of the
company’s business units ups the ante on that bet, while indicating that it isn’t working yet.
Lilly as an employment destination
Eli Lilly and Co. has experienced a string of setbacks in recent years. Is it still a good place to work?
Lilly reorganization to cut 5,500 positions over 2 years
Eli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.
Study weakens Lilly’s fight against price controls
Eli Lilly and Co. and its peers might be back in Congress’ sights as lawmakers hunt for more ways to cut health care
costs. A new study in the influential Health Affairs journal concludes that European drugmakers operating
in markets with pharmaceutical price controls have produced proportionally more innovations than their U.S. counterparts.
On the hook for bariatric surgery
An Indiana Court of Appeals ruling favoring an obese employee is likely to make employers think twice about hiring
overweight people.